A Novel Injectable Polypeptide Nanoparticle Encapsulated <scp>siRNA</scp> Targeting <scp>TGF</scp> ‐β1 and <scp>COX</scp> ‐2 for Localized Fat Reduction <scp>II</scp> : Phase I Clinical Trial

Authors

Institutions

Publication Details

Journal
Journal of Cosmetic Dermatology
Published
2024-12-18
DOI
https://doi.org/10.1111/jocd.16722
Citations
6
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
2.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF ‐β1 and COX ‐2 for Localized Fat Reduction II : Phase I Clinical Trial

Patrick Lu, Michael Molyneaux, Mark S. Nestor, Vishnu Bhupalam et al.
6 citations
Journal of Cosmetic Dermatology
Mesenchymal stem cell research
2.63
article

A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF ‐β1 and COX ‐2 for Localized Fat Reduction II : Phase I Clinical Trial

Patrick Lu, Michael Molyneaux, Mark S. Nestor, Vishnu Bhupalam, Nardin Awad, J. Hetzel
article en
6 citations

Abstract

No abstract available for this paper.
Journal of Cosmetic DermatologyVol. 24(2)
University of Miami (US), Center for Clinical and Cosmetic Research (US), Sirnaomics (United States) (US)
Good health and well-being
Openalex Percentile: Top 9%
Mesenchymal stem cell research
2.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.